New England Asset Management Inc Pfizer Inc Transaction History

New England Asset Management Inc

$606 Million
Q2 2025

A detailed history of New England Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, New England Asset Management Inc holds 185,128 shares of PFE stock, worth $5.07 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

185,128

Previous 155,448 19.09%

Holding current value

$5.07 Million

Previous $3.94 Million 13.91%

% of portfolio

0.74%

Previous 0.68%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$21.59 - $24.84 $640,791 - $737,251	29,680 Added 19.09%	185,128 $4.49 Million
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $25,635 - $27,808	1,025 Added 0.66%	155,448 $3.94 Million
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $530,472 - $645,764	-21,390 Reduced 12.17%	154,423 $4.1 Million
Q3 2024 Nov 07, 2024	BUY	$27.7 - $31.39 $14,265 - $16,165	515 Added 0.29%	175,813 $5.09 Million
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $70,728 - $82,880	-2,800 Reduced 1.57%	175,298 $4.9 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $207,120 - $237,840	8,000 Added 4.7%	178,098 $4.94 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $71,674 - $93,097	2,743 Added 1.64%	170,098 $4.9 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $256,880 - $300,267	-8,005 Reduced 4.56%	167,355 $5.55 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $306,060 - $398,445	-7,770 Reduced 4.24%	175,360 $7.15 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $199,481 - $260,401	-4,778 Reduced 2.54%	183,130 $9.39 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $395,065 - $482,275	9,028 Added 5.05%	187,908 $8.22 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $51,183 - $60,687	1,100 Added 0.62%	178,880 $9.38 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $123,525 - $153,063	2,700 Added 1.54%	177,780 $9.2 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $254,118 - $376,687	6,150 Added 3.64%	175,080 $10.3 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $414,205 - $532,082	10,553 Added 6.66%	168,930 $7.27 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $71,640 - $81,156	1,995 Added 1.28%	158,377 $6.2 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $80,376 - $90,648	2,400 Added 1.56%	156,382 $5.67 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $93,716 - $119,168	2,800 Added 1.85%	153,982 $5.67 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $130,175 - $152,725	-4,100 Reduced 2.64%	151,182 $5.55 Million
Q2 2020 Aug 17, 2020	SELL	$30.12 - $36.54 $310,236 - $376,362	-10,300 Reduced 6.22%	155,282 $5.08 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $236,512 - $337,925	8,750 Added 5.58%	165,582 $5.41 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $69,132 - $78,456	-2,100 Reduced 1.32%	156,832 $6.15 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $48,073 - $53,976	-1,300 Reduced 0.81%	158,932 $6.89 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $237,000 - $260,384	6,320 Added 4.11%	160,232 $6.81 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $178,885 - $203,949	4,650 Added 3.12%	153,912 $6.72 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $13,615 - $16,514	395 Added 0.27%	149,262 $6.58 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $61,342 - $65,397	1,860 Added 1.27%	148,867 $5.4 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $38,292 - $44,424	1,200 Added 0.82%	147,007 $5.22 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $83,150 - $88,225	-2,500 Reduced 1.69%	145,807 $5.28 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $4.6 Million - $5.06 Million	148,307	148,307 $5.3 Million

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on New England Asset Management Inc with notifications on news.

Account

New England Asset Management Inc Pfizer Inc Transaction History